A Bioequivalence Pivotal Study of SYN010 HFA Inhaler and Symbicort ® 160/4.5 in Healthy Volunteers Without Charcoal Block
Conditions: Asthma; COPD Interventions: Drug: Budesonide; Drug: Formoterol Sponsor: Intech Biopharm Ltd. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 31, 2020 Category: Research Source Type: clinical trials
